Highlights Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Market Closed - Nasdaq Stockholm Other stock markets 08:52:21 17/05/2024 pm IST			5-day change	1st Jan Change
99.8 ^SEK	-2.63%		0.00%	+26.97%

14/05	Devyser Diagnostics AB Appoints Thomas Eklund as Member of the Board of Directors	CI
08/05	Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Devyser Receives IVDR Approval for Post-Transplant Monitoring Software	25/04	CI
Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG	23/04	CI
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test	11/03	CI
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient	29/02	CI
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02	CI
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	20/02	CI
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted	17/01	MT
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted	17/01	CI
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits	15/01	MT
Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy	15/01	CI
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US	08/01	MT
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests	08/01	CI
Sweden’s Devyser Wins $6 Million Tender for Cystic Fibrosis Diagnostic Tool in Italy	11/12	MT
Devyser Wins Approximately SEK 2 Million Tender for Cystic Fibrosis	11/12	CI
Devyser Diagnostics Bags Non-invasive Fetal RHD Test Tender in Wales	05/12	MT
Devyser wins tender for non-invasive fetal RHD testing in Wales	05/12	CI
Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Devyser and Thermo Fisher Scientific Collaborate to Promote Laboratory Services to Advance Pharmaceutical Research	13/23/13	CI
Thermo Fisher Scientific to Sell Devyser Diagnostics' Transplantation Products in Brazil	06/23/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Highlights

Filters